We are looking for a highly motivated Ph.D. with substantial AAV expertise. Our targeted gene therapy team at Aix-Marseille University is developing cutting-edge strategies to treat mouse models of Rett syndrome. Rett syndrome is a severe neurological disorder caused by mutations of the MECP2 (Methyl CpG binding protein 2) gene, located on the X chromosome. The posdoc would play a pivotal role in this team by designing new AAV vectors as well as developing innovative approches to target the brain. The AAV vectors generated will be used to correct/cure the « Rett Syndrome » phenotype in mouse models. In vivo phenotyping and molecular/cellular évaluations will be performed.
Salary:
Salary is commensurate with experience. Around 2200€/month
Duration :
27 months from September 01 2018 till December 31th 2020
Requirements :
Ph.D. with >2 years experience working with AAV vectors and in vivo delivery, molecular biology, and mice phenotyping.
Location:
Inserm UMR_S 1251 – MMG
Faculté de Médecine de La Timone
27 boulevard Jean Moulin
13385 Marseille cedex 5
FRANCE
http://www.germaco.net/Accueil_gb.html
https://www.marseille-medical-genetics.org/
Contact: If you are interested, please submit your CV and the names and contact information for references to jean-christophe.roux@univ-amu.fr
http://www.researcherid.com/rid/S-2563-2016
https://orcid.org/0000-0002-9721-8844
